e-learning
resources
London 2016
Wednesday, 07.09.2016
Mesothelioma and malignant pleural disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures
Uffe Bødtger (Holmegaard, Denmark), Dennis V. Lindegaard, Simon Reuter, Christian B. Laursen, Uffe Bødtger
Source:
International Congress 2016 – Mesothelioma and malignant pleural disease
Session:
Mesothelioma and malignant pleural disease
Session type:
Poster Discussion
Number:
5081
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Uffe Bødtger (Holmegaard, Denmark), Dennis V. Lindegaard, Simon Reuter, Christian B. Laursen, Uffe Bødtger. Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures. Eur Respir J 2016; 48: Suppl. 60, 5081
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Comparison between bronchoscopy, closed (Abram’s) and medical thoracoscopic pleural biopsies in undiagnosed pleural effusions
Source: International Congress 2016 – Pleural diseases
Year: 2016
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
EBUS in real life: Primary diagnosis and mediastinal staging
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Diagnostic accuracy of pleural fluid cytology compared to pleural biopsy histology obtained via thoracoscopy
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Efficacy of conventional TBNA in patients with mediastinal adenopathies - A role of cytopathologist
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
Clinical and radiological predictors of post-procedure pneumothorax complicating CT-guided lung biopsy
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Rapid on-site evaluation of medical thoracoscopic biopsy specimens for the diagnosis of pleural disease
Source: International Congress 2014 – The planet of the pleura
Year: 2014
Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
No additional diagnostic gain of mediastinoscopy following sytematically and thouroughly performed mediastinal staging by EBUS-TBNA
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Utility of sending pleural fluid for cytology at the time of thoracoscopy and pleural biopsy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Predictive value of pre-test clinical diagnosis for mediastinal lymphadenopathy compared to histological outcomes from cervical mediastinoscopy
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Utility of EUS-B-FNA for the diagnosis of EBUS-TBNA inaccessible intrathoracic lesions
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
Draining pleural effusions before radiological imaging does not improve diagnostic capability
Source: International Congress 2015 – Invasive and surgical procedures: the clinical point of view
Year: 2015
CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
EBUS-TBNA in the diagnosis of haematological malignancies; overcoming the challenge
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept